Peptide library · Small molecules

What is
5-Amino-1MQ?

5-Amino-1MQ is a small molecule, not a peptide. This guide covers what researchers measured, what is not known, and what official records can—and cannot—say about its status. If you searched “5 amino 1mq,” start with the molecule’s identity.

Short answerCompound research · 6 min read · Updated 21 Nov 2026

5-amino-1MQ is 5-amino-1-methylquinolinium, a small-molecule quinolinium compound, not a peptide or amino-acid chain. Its published research is in cells and mice (T4, T3); we found no study that gave it to people (PubMed and ClinicalTrials.gov, 21 November 2026). Drugs@FDA and the UK’s emc database list no medicine containing it.

Key takeaways

  • 5-Amino-1MQ is a small molecule, not a peptide.
  • The primary studies discussed here used cells or animals; they do not establish an effect in people.
  • A database search shows what was listed on the date searched; it is not a legal conclusion.
  • A useful lab report should identify the tested material, the analytical method, and the lot it represents.

01Evidence at a glance

The evidence ladder shows the kinds of direct research located, not a score or a measure of certainty.

Cell studies
Reported
Animal studies
Reported
Studies in people
None found

The bars show which kinds of study exist, not a score. A row with no study we found (PubMed and ClinicalTrials.gov, 21 Nov 2026) is drawn at 0%.

Sources: Neelakantan et al., 2018 and Babula et al., 2024.

In evidence-tier terms, cell work is T4 and animal work is T3. Neither tier establishes an effect in people. The papers discussed below are preclinical research, not human treatment evidence.

02What 5-Amino-1MQ is

5-Amino-1MQ is the short name for 5-amino-1-methylquinolinium. It is a small organic molecule studied as an inhibitor of nicotinamide N-methyltransferase, or NNMT. It is not a peptide: its structure is not a chain of amino acids linked by peptide bonds.

For a basic comparison of molecule classes, see peptides, proteins, and amino acids.

NNMT is the enzyme researchers targeted in these studies. In the 2018 paper, the researchers examined NNMT inhibition in cell assays and in a mouse model. That design can show what happened in those experimental systems; it cannot establish what happens in people.

03What the key studies measured

These are study designs and measured endpoints, not evidence of a human outcome.

StudyModel and designEvidence tier and limit
Neelakantan et al., 2018Cell assays and a diet-induced-obesity mouse model; researchers examined NNMT inhibition, cell permeability, and metabolic and tissue measures. The mouse experiment included 9 animals per cohort.T4 in cells; T3 in mice. It was not a study in people.
Babula et al., 2024Diet-induced-obesity mice; the paper assessed body-composition and metabolic measures, liver findings, and pharmacokinetics. The reported mouse groups included 8 animals per group in the main study.T3. The paper reports animal research; it does not establish human effects or safety.

The 2024 paper disclosed financial ties: one author founded Ridgeline Therapeutics, another was its paid employee, and two authors were former employees. Those ties matter when weighing a preclinical result.

For grades used across this site, see how evidence grades work. What a lab report for it should show is in the section below; the general method is in how to read a COA.

04Where official records stand by country

A register can help check for an authorization entry. It does not decide every legal question about a substance or a particular product.

CountryOfficial recordWhat we can say
United StatesDrugs@FDA (through openFDA, data to 20 Nov 2026) and FDA’s list of substances nominated for compounding under section 503A (updated 14 May 2026)No product with 5-amino-1-methylquinolinium as an active ingredient, and no entry on the nominations list (searched 21 Nov 2026). We draw no legal conclusion of our own.
United KingdomThe emc medicines databaseNo search results for 5-amino-1MQ or methylquinolinium (21 Nov 2026); it is not the full UK register.
AustraliaThe Poisons Standard October 2026No entry for 5-amino-1-methylquinolinium or methylquinolinium (searched 21 Nov 2026); we draw no scheduling conclusion of our own.

These are dated searches, not legal conclusions. For broader regulator context, see the legal-status overview.

05What a lab report should show

A certificate of analysis (COA) is useful only if it can be tied to the material it describes and explains what the tests establish. For a small molecule such as 5-Amino-1MQ, check whether the report makes these details clear:

1
Material identity

The chemical name and the form tested should be stated. If a salt form is claimed, ask whether the report identifies that form rather than only a related ion.

2
Test method

The method and the result should be named. Ask which test supports identity and which, if any, supports a purity estimate.

3
Lot and test date

The report should identify the lot tested and give a test date, so you can compare it with the material label and the report’s scope.

A report is evidence about the tested sample, not a substitute for the underlying method or a guarantee about another sample. Use the supplier audit guide to check the report’s traceability and scope.

06What we don't know

  • Whether 5-Amino-1MQ produces any effect in people. The studies discussed here used cells and animals.
  • Its human safety profile, including long-term safety. The animal studies cited here do not establish that.
  • Whether a vial labelled 5-Amino-1MQ contains that compound or a particular salt form. A label alone does not identify a tested sample.
  • A legal conclusion for the United States, United Kingdom or Australia. The searches above do not give one.

Checked 21 November 2026. This is a plain-English summary of public studies and regulator records, not legal or medical advice.

RefSources

  1. National Center for Biotechnology Information. PubChem compound record: 5-amino-1-methylquinolinium. Chemical database record. pubchem.ncbi.nlm.nih.gov/compound/5-Amino-1-methylquinoliniu…
  2. Neelakantan H, Vance V, Wetzel MD, et al. [NNMT inhibitor study in cells and diet-induced obese mice.] Biochemical Pharmacology, 2018;147:141–152. PMID 29155147; full text PMC5826726 read 21 Nov 2026. pubmed.ncbi.nlm.nih.gov/29155147/
  3. Babula JJ, Bui D, Stevenson HL, Watowich SJ, Neelakantan H. [NNMT inhibitor study in diet-induced obese mice.] Diabetes, Obesity and Metabolism, 2024;26(11):5272–5282. PMID 39161060; author manuscript PMC11622326 read 21 Nov 2026. onlinelibrary.wiley.com/doi/10.1111/dom.15879
  4. U.S. Food and Drug Administration. Drugs@FDA data through the openFDA API (last updated 20 Nov 2026): no product with 5-amino-1-methylquinolinium as an active ingredient. Database query, 21 Nov 2026. api.fda.gov/drug/drugsfda.json?search=products.active_ingred…
  5. U.S. Food and Drug Administration. Bulk drug substances nominated for use in compounding under section 503A (categories 1 to 3). List updated 14 May 2026; read 21 Nov 2026. www.fda.gov/media/94155/download
  6. Electronic medicines compendium (emc). Searches for 5-amino-1MQ and methylquinolinium: “No search results” (control search, somatropin, returned results). Database searches, 21 Nov 2026. www.medicines.org.uk/emc/search?q=methylquinolinium
  7. Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327). Federal Register of Legislation, commenced 1 Oct 2026; text searched 21 Nov 2026 for methylquinolinium and 5-amino-1-methylquinolinium. www.legislation.gov.au/F2026L01327/latest/text
  8. PubMed search: 5-amino-1-methylquinolinium, 5A1MQ or 5-amino-1MQ with human terms: 3 records, cell, tissue and mouse work, none giving it to people; ClinicalTrials.gov: no record. Database searches, 21 Nov 2026. pubmed.ncbi.nlm.nih.gov/?term=%28%225-amino-1-methylquinolin…

Plain-English summary of public sources, not legal or medical advice. Last checked 21 Nov 2026.

Questions

Is 5-Amino-1MQ a peptide?

No. It is a small-molecule quinolinium compound, not a chain of amino acids.

What kind of research has been published on 5-Amino-1MQ?

The primary papers cited here report cell and animal research. They do not establish an effect or safety profile in people.

Is 5-Amino-1MQ listed as a medicine in the US, UK or Australia?

We found no medicine containing it in Drugs@FDA or the UK’s emc database, and no entry in Australia’s Poisons Standard (21 Nov 2026). Those are database searches, not legal conclusions.

What should a COA for 5-Amino-1MQ show?

It should identify the material and the form tested, name the analytical methods and results, and link those results to a lot and test date. A report’s scope matters as much as its headline result.

Evidence before hype.

One email a week: new research explained and regulatory changes. No prices, no hype.

Get the 6:00 brief

Free. Unsubscribe any time.

Written by 6AM Research. Drafted from primary sources; every claim links to its source, and the page is dated. Editorial policy · How we check every page